Serina Therapeutics share price logo

Serina Therapeutics

AMEX: SER

$1.12

-0.08

(-6.67%)

as on

Serina Therapeutics Stock Performance

as on November 21, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $1.06
    $1.26
    downward going graph

    5.36%

    Downside

    12.50%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $1.06
    $4.26
    downward going graph

    5.36%

    Downside

    280.36%

    Upside

    downward going graph

Serina Therapeutics share price movements today

Previous Close
$1.20
Open
$1.16
Volume
554.6K
Market Cap
$31.9M
Day's Low - High
$1.06 - $1.26
52 Week Low - High
$1.06 - $4.26

Serina Therapeutics Historical Returns

1 Month Return
-36.72 %
3 Month Return
-60.98 %
1 Year Return
-71.93 %
3 Year Return
0 %
5 Year Return
0 %

Serina Therapeutics Stock Fundamentals & Key Indicators

Check Serina Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$31.9M

EPS (TTM)

-1.75

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

-0.43%

PE Ratio (TTM)

-0.69

Industry PE ratio

-3.02

PEG Ratio

-0.11

EBITDA

-25.2M

Revenue (TTM)

125.0K

Profit Margin

-2635.20%

Return On Equity TTM

-195.03%

Serina Therapeutics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Serina Therapeutics with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Buy$31.9MNA-0.69-2635.20%0.00%
Neutral$80.7B-26.07%-28.1528.00%0.00%
StrongBuy$45.7BNA65.0988.39%0.00%
StrongBuy$132.0B181.62%33.2585.53%0.00%
Buy$95.5B41.06%19.6585.77%0.41%

Stock Returns calculator for Serina Therapeutics Stock including INR - Dollar returns

The Serina Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

Serina Therapeutics investment value today

Current value as on today

₹29,019

Returns

-₹70,981

(-70.98%)

Returns from Serina Therapeutics Stock

-₹71,930 (-71.93%)

Dollar Impact

₹949 (+0.95%)

Analyst Recommendation on Serina Therapeutics Stock

Based on 2 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 2 analysts, 100% of analysts recommend a 'BUY' rating for Serina Therapeutics. Average target price of $9.5

Serina Therapeutics Share Price Target

Get share price movements and forecasts by analysts on Serina Therapeutics.

Current Price

$1.12

Analyzed by

2 Analysts

High

$11

0

Low

$8

Serina Therapeutics target price $0, a slight upside of 0% compared to current price of $1.12. According to 2 analysts rating.

Indian Investors' Interest in Serina Therapeutics Stock

Search interest for Serina Therapeutics Stock has increased by 183% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:183% versus previous 30 day period

Serina Therapeutics Quarterly Profit & Loss

All numbers in Millions USD

Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Total Revenue
-
0
0
-
0
-
-
-
-
0
Gross Profit
-
-2
-2
-
0
-3
-3
0
-
0
Operating Income
-3
-5
-5
-5
-5
-6
-6
-6
-6
-7
EBITDA
5
1
-2
-4
-6
-4
-3
-7
-7
-7
Interest Expense
0
0
0
-
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
5
1
-2
-4
-6
-4
-3
-6
-6
-7
Income Tax Expense
-
-
-
-
-
-
0
0
-
-
Net Income
5
1
-2
-4
-6
-4
-3
-6
-6
-7
Net Profit Margin
0.00%
100.00%
100.00%
0.00%
87.69%
0.00%
0.00%
0.00%
0.00%
100.00%

Serina Therapeutics Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Mar 2019
Dec 2019
Mar 2021
Dec 2021
Mar 2023
Dec 2023
Dec 2024
Dec 2025
Total Revenue
1
1
1
0
3
0
3
0
-
Gross Profit
0
0
0
-1
0
0
3
0
-
Operating Income
-8
-10
-12
-10
-1
-2
-3
-17
-24
EBITDA
-7
-7
-11
-8
-1
-2
5
-10
-18
Interest Expense
0
-
-
0
0
0
0
0
0
Depreciation
0
0
0
1
0
0
0
0
0
Income Before Tax
-6
-7
-12
-10
-1
-2
5
-11
-19
Income Tax Expense
-
-
0
-
-
-
-
-
0
Net Income
-6
-7
-12
-10
-1
-2
5
-11
-19
Net Profit Margin
51.21%
39.76%
42.22%
-2272.22%
100.00%
100.00%
97.15%
-246.43%
0.00%

Serina Therapeutics Quarterly Cash Flow

All numbers in Millions USD

Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Net Income
5
1
-2
-4
-6
-4
-3
-6
-6
-7
Operating Cash Flow
-8
-2
-4
-4
-3
-3
-6
-4
-6
-5
Investing Cash Flow
-
0
0
-
0
0
-
0
0
0
Financing Cash Flow
5
0
5
4
5
6
0
26
5
1
Change in Cash
-2
-2
0
0
1
2
-5
21
-1
-3

Serina Therapeutics Annual Cash Flow

All numbers in Millions USD

Dec 2017
Mar 2019
Dec 2019
Mar 2021
Dec 2021
Mar 2023
Dec 2023
Dec 2024
Dec 2025
Net Income
-6
-7
-12
-10
-1
-2
5
-11
-19
Operating Cash Flow
-6
-7
-10
-7
-2
-2
-2
-17
-17
Investing Cash Flow
0
1
0
0
0
0
0
0
0
Financing Cash Flow
13
6
6
5
1
1
10
13
17
Change in Cash
7
0
-4
-1
0
0
7
-3
0

Global Institutional Holdings in Serina Therapeutics

Check out the Institutions with significant holdings in Serina Therapeutics.

Funds
Holdings
Shares Held
Gregory Bailey
32.23%
8564382
Jay Venkatesan
0.87%
232294
VANGUARD INDEX FUNDS
0.60%
159136
Vanguard
0.59%
156733
Fidelity Concord Street Trust
0.20%
51901

Insights on Serina Therapeutics

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 722.1% return, outperforming this stock by 794.0%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, SER stock has moved down by -19.4%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 130.0K → 125.0K (in $), with an average decrease of 3.9% per quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, -6.35M → -7.90M (in $), with an average decrease of 24.4% per quarter

About Serina Therapeutics

Serina Therapeutics, Inc., a biotechnology firm, focuses on creating pharmaceutical treatments for neurological conditions and pain. Its primary investigational drug, SER 252, is a POZ conjugate intended for managing Parkinson's disease. The company is also developing SER 227 for prolonged pain relief, SER 214, another candidate for Parkinson's disease, and SER 228 to treat epilepsy. Beyond these, Serina Therapeutics leverages its POZ technology in producing ribonucleic acid (RNA) vaccines delivered via lipid nanoparticles for combating infectious diseases. This company was established in 2006 and is headquartered in Huntsville, Alabama.
OrganisationSerina Therapeutics
Headquarters601 Genome Way, Huntsville, AL, 35806, US
IndustryBiotechnology
CEOSteven A. Ledger

Key Management of Serina Therapeutics

Name

Title

Dr. Balkrishan Gill Ph.D.

Executive Co-Chairman of the Board

Mr. Steven A. Ledger

CEO & Director

Dr. J. Milton Harris Ph.D.

Co-Founder, Director Emeritus & Chair of Scientific Advisory Board

Dr. Srini Tenjarla Ph.D.

Chief Technical Operations Officer

Dr. Randall W. Moreadith M.D., Ph.D.

Chief Development Officer

Mr. Gregory S. Curhan

Chief Financial Officer

Dr. Joshua Thomas Ph.D.

Head of Chemistry

FAQs

What is Serina Therapeutics share price today?

Serina Therapeutics share price today is $1.12 as on at the close of the market. Serina Therapeutics share today touched a day high of $1.26 and a low of $1.06.

What is the 52 week high and 52 week low for Serina Therapeutics share?

Serina Therapeutics share touched a 52 week high of $4.26 on and a 52 week low of $1.06 on . Serina Therapeutics stock price today i.e. is closed at $1.12,which is 73.71% down from its 52 week high and 5.66% up from its 52 week low.

What is Serina Therapeutics's market capitalisation today?

Serina Therapeutics market capitalisation is $0.00T as on .

How to invest in Serina Therapeutics Stock (SER) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Serina Therapeutics on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Serina Therapeutics Stock (SER) from India?

Indian investors can start investing in Serina Therapeutics (SER) shares with as little as ₹92.66999816894531 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹926.70 in Serina Therapeutics stock (as per the Rupee-Dollar exchange rate as on ). Based on Serina Therapeutics share’s latest price of $1.12 as on November 21, 2026 at 8:46 am IST, you will get 8.9286 shares of Serina Therapeutics. Learn more about fractional shares .